InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Sachdev Amit, Director. Director active across 3 companies, notably Vertex Pharmaceuticals INC / MA. Aggregated, 38 filings have been recorded. Split: 0 buy · 10 sells. Total volume traded: €4.5m. History available since 17 May 2021. The latest transaction was filed on 21 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sachdev Amit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
8,251 shares0Common StockSEC:0000875320-26-000251:0
1,518 shares@ US$485.1110.4% of flowCommon StockSEC:0000875320-26-000118:0
23,479 shares@ US$155.5751.7% of flowCommon StockSEC:0000875320-26-000102:0
5,789 shares0Common StockSEC:0000875320-26-000096:0
3,548 shares@ US$487.7624.3% of flowCommon StockSEC:0000875320-26-000074:0
2,057 shares@ US$468.4113.5% of flowCommon StockSEC:0000875320-26-000050:0
7,866 shares0Common StockSEC:0000875320-26-000024:0
3,703 shares@ US$479.619.7% of flowCommon StockSEC:0000875320-25-000133:0
2,470 shares@ US$483.286.5% of flowCommon StockSEC:0000875320-25-000113:0
2,139 shares@ US$463.465.4% of flowCommon StockSEC:0000875320-25-000093:0
6,211 shares0Common StockSEC:0000875320-25-000069:0
2,056 shares@ US$467.985.4% of flowCommon StockSEC:0000875320-25-000046:0
8,210 shares0Common StockSEC:0000875320-25-000022:0
4,600 shares0Common StockSEC:0000875320-24-000172:0
32 shares@ US$430.930.1% of flowCommon StockSEC:0000875320-24-000154:0
2,469 shares@ US$431.795.7% of flowCommon StockSEC:0000875320-24-000107:0
3,191 shares@ US$421.777.2% of flowCommon StockSEC:0000875320-24-000091:0
3,498 shares@ US$424.017.9% of flowCommon StockSEC:0000875320-24-000078:0
2,022 shares@ US$422.744.6% of flowCommon StockSEC:0000875320-24-000053:0
5,814 shares0Common StockSEC:0000875320-24-000030:0
35 shares@ US$369.920.1% of flowCommon StockSEC:0000875320-23-000041:0
10,031 shares@ US$350.0018.4% of flowCommon StockSEC:0000899243-23-018109:0
2,468 shares@ US$289.123.9% of flowCommon StockSEC:0001209191-23-013744:0
3,498 shares@ US$292.855.5% of flowCommon StockSEC:0001209191-23-011699:0
2,611 shares@ US$294.334.1% of flowCommon StockSEC:0001209191-23-009226:0
25 of 38 declarations
About Sachdev Amit
Sachdev Amit is Executive Director, Chief Patient and Ext Af Off, and a director at Vertex Pharmaceuticals INC / MA, VERTEX PHARMACEUTICALS INC / MA, and a director at Eiger BioPharmaceuticals, Inc. He has 37 filings in total. Across the 37 sampled filings, the period runs from 2016-02-04 to 2026-02-26, with 0 EUR of buys and 4471086 EUR of sells, and the most frequent transaction nature is tax withholding.
